Almonertinib 110 MG
NCC2380
Phase 2 small_molecule active
Quick answer
Almonertinib 110 MG for Rare Tumor is a Phase 2 program (small_molecule) at Chinese University of Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chinese University of Hong Kong
- Indication
- Rare Tumor
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active